Amdocs heads into its fiscal fourth-quarter report with a better story than it has had in some time, and a single number that could undercut it. Last quarter, management moved its agentic AI platform, AOS, from slideware to signed paper, landing an end-to-end deal to run Liberty Latin America's entire IT operation. Yet the 12-month backlog slipped $20 million sequentially to $4.26 billion, the first decline after gains in each of the two prior quarters. The September-quarter results, due after the close on November 3, will help show which of those signals deserves more weight.
The headline expectations are unlikely to be the problem. Consensus calls for non-GAAP earnings of $1.98 per share on revenue of $1.19 billion, up about 3.5% from the $1.15 billion reported a year earlier. That is steady, low-single-digit growth, consistent with a mature telecom software franchise rather than a breakout. Management guided to $1.94 to $2.00 per share on revenue of $1.175 billion to $1.215 billion, so the Street sits in the upper half of the earnings range and a touch below the revenue midpoint. The Earnings Whisper of $2.00 sits right at the top of guidance, a modest premium that suggests a small beat is expected rather than hoped for. Amdocs tightened its full-year ranges around unchanged midpoints last quarter, implying roughly 3% constant-currency growth and about 6% non-GAAP EPS growth, and companies rarely narrow ranges unless they can see the finish line. A miss here would be genuinely surprising.
The more consequential test is whether the new catalysts are filtering into forward indicators. Management said Liberty Latin America was only partly reflected in backlog, which offers a ready explanation for last quarter's dip but also creates an obligation. If more of that contract, along with the new multi-year South American managed services agreement on the full BOSS stack, shows up this quarter, backlog should resume growing and the year-over-year rate, which has hovered around 2.6% to 2.7%, should firm. Another sequential decline would make the AOS enthusiasm look more like a pipeline story than a revenue story. The count of AOS engagements, which reached 10 last quarter from an initial group of five named customers, is a second gauge worth tracking for continued momentum.
Margins and cash deserve attention as well. Amdocs has held its full-year non-GAAP operating margin target at 21.3% to 21.9% all year, deliberately reinvesting efficiency savings into generative AI and AOS. That keeps the profit story flat to slightly up, and the CEO's caution about uncertain future token and computing costs raises a fair question about how profitable agentic offerings will ultimately be. Free cash flow has been a bright spot, with roughly three quarters of the $710 million to $730 million target already in hand, but days sales outstanding jumped five days sequentially to 78, so collections matter. Any update on the previously disclosed revenue decline at T-Mobile will also shape views of the core North American base.
The market has already leaned toward the optimistic reading. Shares have gained 9.3% since the last report while the S&P 500 slipped 1.3%, and sentiment, though still bearish, has eased from the prior quarter. At $62.74, the stock sits just below its 200-day moving average and about 2.6% under its post-earnings high of $64.39, close enough that a convincing report could push it through resistance, while its trading range has narrowed considerably from the prior quarter's wide swings.
Ultimately, delivering inside guidance is the minimum. For the improving narrative to hold, Amdocs needs to show that Liberty Latin America and the broader AOS push are translating into renewed backlog growth, and that the next leg of the story can carry growth beyond the roughly 3% pace investors have come to expect.